Clinical MedicineUpdated Aug 18, 2026Version v1
Reviewed milestones, validation shifts, standards, datasets, and debates linked to public evidence.
Evidence from Science indicates that The neuronal environment, maintained by glia and the blood-brain barrier, is crucial for neuronal function. This is tracked as a clinical because it changes how Blood Biomarkers for Neurodegeneration is understood, validated, or applied. It is supported by 3 papers in the same timeline signal.
Evidence from JAMA Neurology indicates that Plasma NFL levels are significantly higher in MCI and AD dementia patients compared to controls. This is tracked as a standard because it changes how Blood Biomarkers for Neurodegeneration is understood, validated, or applied.